Results 91 to 100 of about 2,997 (148)

Extrafine single inhaler triple therapy effectiveness in COPD patients previously treated with multiple-inhaler triple therapy: the TRIWIN study

Therapeutic Advances in Respiratory Disease
Background: The extrafine single inhaler triple therapy (efSITT) containing beclomethasone dipropionate/formoterol fumarate/glycopyrronium 87/5/9 μg has proved to be efficacious in patients with chronic obstructive pulmonary disease (COPD) in randomized ...
Paschalis Steiropoulos, Niki Georgatou, George Krommidas, Konstantinos Bartziokas, Aliki Korkontzelou, Panos Katerelos, Petros Efstathopoulos, Dimosthenis Papapetrou, Stavros Theodorakis, Konstantinos Porpodis   +9 more
doaj   +1 more source

Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK

, 2016
Oskar Eklund,1 Faraz Afzal,2 Fredrik Borgström,1 Jason Flavin,3 Andrew Ternouth,4 Maria Eugenia Ojanguren,5 Carlos Crespo,5 Mike Baldwin6 1Quantify Research AB, Stockholm, Sweden; 2Boehringer Ingelheim, Asker, Norway; 3Boehringer Ingelheim ...
Flavin J, Ternouth A, Ojanguren ME, Crespo C, Baldwin M, Borgström F, Afzal F, Eklund O   +7 more
core  

Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study

International Journal of COPD, 2013
Ronald Dahl,1 Dalal Jadayel,2 Vijay KT Alagappan,3 Hungta Chen,3 Donald Banerji31Department of Dermatology, Allergy Centre, Odense University Hospital, Odense, Denmark; 2Novartis Horsham Research Centre, Horsham, UK; 3Novartis Pharmaceuticals Corporation,
Dahl R, Jadayel D, Alagappan VKT, Chen H, Banerji D   +4 more
doaj  

A stability-indicating RP-HPLC method for simultaneous quantification of thirteen known and unknown impurities in fluticasone furoate–vilanterol–glycopyrronium combination products

Discover Chemistry
Rigorous impurity monitoring of fixed-dose combination inhalation products containing fluticasone furoate, vilanterol, and glycopyrronium is essential for ensuring therapeutic efficacy and regulatory compliance.
Shrikant Vinod Kulkarni, Sharad Panditrao Panchgalle, Santosh Digambarrao Deosarkar, Vijaykumar Shivdas More   +3 more
doaj   +1 more source

Spotlight on glycopyrronium/formoterol fumarate inhalation aerosol in the management of COPD: design, development, and place in therapy

International Journal of COPD, 2017
Santosh Dhungana, Gerard J Criner Department of Thoracic Medicine and Surgery, Temple Lung Center, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA Abstract: Long-acting bronchodilators are the mainstay of the treatment of COPD.
Dhungana S, Criner GJ
doaj  

Glycopyrronium 320 μg/ mL in children and adolescents with severe sialorrhoea and neurodisabilities: A randomized, double‐blind, placebo‐controlled trial

International audienceAbstract Aim To investigate the efficacy, safety, and impact on quality of life (QoL) of an oral formulation of 320 μg/mL glycopyrronium designed for children.
Shaw, Helen, Schwartz, Déborah, Fayoux, Pierre, Dinomais, Mickael, Villain, Frédéric, Letellier, Guy, Auvin, Stéphane, Rondeau, Stéphane   +7 more
core   +1 more source

The combination of indacaterol and glycopyrronium has effects on symptoms, lung function, and rate of exacerbations in COPD patients.

, 2014
Long-acting bronchodilators are the mainstay of pharmacological therapy for chronic obstructive pulmonary disease (COPD). This paper reviews the efficacy of the once-daily fixed-dose dual bronchodilator combination of indacaterol and glycopyrronium in ...
Ulrik, Charlotte Suppli
core   +1 more source

Beclomethasone Dipropionate, Glycopyrronium (as Bromide), and Formoterol Fumarate Dihydrate (Trimbow)

Reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class.
CDA-AMC
core   +1 more source

Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis

International Journal of COPD, 2018
Mohamed Ismail Abdul Aziz,1,* Ling Eng Tan,1,* David Bin-Chia Wu,1 Fiona Pearce,1 Gerald Seng Wee Chua,2 Liang Lin,1 Ping-Tee Tan,1 Kwong Ng1 1Agency for Care Effectiveness, Ministry of Health, Singapore; 2Division of Medicine, Ng Teng Fong General ...
Abdul Aziz MI, Tan LE, Wu DB, Pearce F, Chua GSW, Lin L, Tan PT, Ng K   +7 more
doaj  

Clinical role of dual bronchodilation with an indacaterol–glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of life

International Journal of COPD, 2015
Andrea Rossi,1 Erika Zanardi,2 Venerino Poletti,3 Mario Cazzola4 1Pulmonary Unit, University of Verona, Verona, 2Department of Respiratory and General Rehabilitation, ULSS 20, Verona, 3Pulmonary Unit, GB Morgani Hospital, AUSL 20, Forli, 4Pulmonary
Rossi A, Zanardi E, Poletti V, Cazzola M
doaj